BioSpace News Archive

Varex Imaging Corporation (Nasdaq: VREX) today provided an update on the novel Coronavirus (COVID-19) and its business operations. COVID-19 Update Varex, like other businesses, continues to closely monitor the changing landscape associated with the spread of COVID-19. As an “essential business” dedicated to providing components needed to combat COVID-19 and maintain essential infrastructure, the company’s glo

Tricida Announces Multiple Data Presentations on Veverimer and Metabolic Acidosis to Be Given at the Virtual National Kidney Foundation 2020 Spring Clinical Meetings SOUTH SAN FRANCISCO, Calif.--( BUSINESS WIRE )-- Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical company focused on the development and commercialization of its drug candidate, veverimer (TRC101), a non-absorbed, orally-administered polymer designed to treat metabolic acidosis in patients wi

ProtoKinetix, Incorporated ( www.protokinetix.com ) (the “Company” or “ProtoKinetix”) (OTCQB: PKTX ), a clinical-stage biomedical company, today announced an update to the Press Release of January 24, 2020 . We have now completed the sterilization, quality assurance, labeling of the AAGP® (PKX-001) and are ready to ship the final product to the University of Alberta upon receipt of the NOL from Health Canada for the co

Ethismos Research, developing pharmaceutical treatments for chronic pain management, severe depression, and substance use disorders, announced that research on lead compound, amitifadine, was published online in the peer-reviewed journal, Psychopharmacology, earlier this month.

COVID-19 task force established to support enrolled patients Participating medical centers implemented safety measures and currently enrolling patients

AXIM ® Biotechnologies, Inc . announced today that its subsidiary Sapphire Biotech, Inc. (“Sapphire”) has completed pre-clinical drug studies on a new compound, SPX-1009, demonstrating 10 times greater potency than its parent compound, SBI-183, in inhibiting metastasis. “Cancer

Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic medical device and technology company focused on unmet needs in global health, announced today that it has received European Patent No. 1,993,600 (“the ‘600 Patent”) entitled " Extracorpo

Hoth Therapeutics, Inc. today announced the pricing of its previously announced “best efforts” underwritten public offering of 1,449,275 shares of its common stock at a price to the public of $3.45 per share. Hoth expects to receive aggregate gross proceeds of approxi

Premier Medical Laboratory Services (PMLS), an industry leading diagnostic laboratory, headquartered in Greenville, South Carolina, is announcing today they are now validated for COVID-19 testing.

CureDuchenne, the leading global nonprofit focused on funding and finding a cure for Duchenne muscular dystrophy, is rolling out a comprehensive suite of online resources for the Duchenne community. This suite of resources is aimed at engaging the community to maintain continuity of care and community building in the current times of global health uncertainty: Coronavirus Health Update Guide